Clinical Trials on Prostatic Hyperplasia in United Kingdom
Total 4265 results
-
Imperial College LondonCompleted
-
Royal Marsden NHS Foundation TrustJanssen, LPRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)United Kingdom
-
H. Lundbeck A/SRecruitingCongenital Adrenal HyperplasiaUnited Kingdom
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
NHS LothianRecruitingProstate Cancer | DNA Damage | Volatile Organic Compounds | Radiotherapy Side EffectsUnited Kingdom
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
Swedish Medical CenterRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Queen Mary University of LondonUniversity College London HospitalsRecruiting
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterPatient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateUnited States
-
Terumo Medical CorporationCompletedBenign Prostatic Hyperplasia | Arteriovenous Malformations | Uterine Fibroid | Hypervascular TumorsUnited States
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
Lawson Health Research InstituteCompletedProstate CancerUnited Kingdom, Australia, Canada
-
Guy's and St Thomas' NHS Foundation TrustCompletedValidating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires (SMACS)Prostate Cancer | Incontinence | Erectile Dysfunction Following Radical ProstatectomyUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingProstate Cancer | Genetic PredispositionUnited Kingdom
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Blue Earth DiagnosticsSyne Qua Non Limited; Innovate UK; IND 2 Results LLCCompletedCancer of the ProstateUnited Kingdom
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
Imperial College LondonWellcome TrustRecruitingProstate Cancer | Metastatic Prostate CancerUnited Kingdom
-
Centocor Research & Development, Inc.CompletedProstate CancerUnited States, United Kingdom, Belgium, Russian Federation
-
St. Bartholomew's HospitalCompletedProstate CancerUnited Kingdom
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
University of California, San FranciscoApproved for marketingProstate Cancer | Prostate Adenocarcinoma | ProstateUnited States
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Exact ImagingCompletedProstate Cancer | Prostatic Neoplasm | Cancer of the PROSTATEUnited States
-
Crozer-Keystone Health SystemRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmUnited States
-
University of UtahTerminatedStage IV Prostate Cancer | Metastatic Prostatic Adenocarcinoma | Castration-Sensitive Prostate Carcinoma | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
Medical Research CouncilCompletedProstate CancerUnited Kingdom, South Africa
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
European Organisation for Research and Treatment...CompletedProstate CancerNetherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom
-
University College London HospitalsCompletedUrinary Incontinence | Sexual Dysfunction | Prostate CancerUnited Kingdom
-
University of Dublin, Trinity CollegeCompletedObesity | Prostate CancerIreland, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
National Cancer Institute (NCI)Enrolling by invitationProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic CancerUnited States
-
King's College LondonKing's College Hospital NHS Trust; Guy's and St Thomas' NHS Foundation Trust; Imperial College Healthcare NHS Trust and other collaboratorsCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Institutes of Health (NIH)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Community Cancer Center, Normal, IllinoisUnknownProstate Cancer | Prostate Neoplasm | Cancer of the ProstateUnited States
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
University of WashingtonNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States